Nephro Care India Ltd vs Soni Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Nephro Care India Ltd is ₹ 83 as of 23 Oct 15:30 . The P/E Ratio of Nephro Care India Ltd is 25.4 as of March 2026 .The P/E Ratio of Soni Medicare Ltd is 0 as of March 2026 . The Market Cap of Nephro Care India Ltd is ₹ 85.32 crore as of March 2026 .The Market Cap of Soni Medicare Ltd is ₹ 0 crore as of March 2026 . The Revenue of Nephro Care India Ltd is ₹ 17.39 crore as of Jun '25 .The Revenue of Soni Medicare Ltd is ₹ 0 crore as of Jun '25 . The EBITDA of Nephro Care India Ltd is ₹ 0.66 crore as of Jun '25 .The EBITDA of Soni Medicare Ltd is ₹ 0 crore as of Jun '25 . The Net Profit of Nephro Care India Ltd is ₹ -0.65 crore as of Jun '25 .The Net Profit of Soni Medicare Ltd is ₹ 0 crore as of Jun '25 . The Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Soni Medicare Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Nephro Care India Ltd

Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

About Soni Medicare Ltd

Soni Medicare Limited was incorporated in the name of 'Soni Hospital Private Limited' on 2 August, 1988 with Registrar of Companies, Jaipur.
On March 30, 1995, name of the Company was changed to Soni Medicare Private Limited.
Later, it converted into a Public Limited Company and a fresh Certificate of Incorporation was obtained on 17 April, 1995.
The name of the Company was changed to Soni Medicare Limited. In order to part-finance its project, the company came out with a public issue in Apr.'96.
The Company was founded under the guidance and dynamic leadership of Dr. B. R. Soni, to run a CT Scan machine in the premises of Soni Hospital and to provide accessible and affordable healthcare.

FAQs for the comparison of Nephro Care India Ltd and Soni Medicare Ltd

Which company has a larger market capitalization, Nephro Care India Ltd or Soni Medicare Ltd?

Market cap of Nephro Care India Ltd is 136 Cr while Market cap of Soni Medicare Ltd is 29 Cr

What are the key factors driving the stock performance of Nephro Care India Ltd and Soni Medicare Ltd?

The stock performance of Nephro Care India Ltd and Soni Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nephro Care India Ltd and Soni Medicare Ltd?

As of October 25, 2026, the Nephro Care India Ltd stock price is INR ₹83.0. On the other hand, Soni Medicare Ltd stock price is INR ₹69.35.

How do dividend payouts of Nephro Care India Ltd and Soni Medicare Ltd compare?

To compare the dividend payouts of Nephro Care India Ltd and Soni Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.